BFPW
ABBV icon

BOK Financial Private Wealth’s AbbVie ABBV Stock Holding History

BOK Financial Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$808K Sell
3,714
-262
-7% -$58.1K 0.05% 93
2025
Q4 		$908K Sell
3,976
-119
-3% -$27.1K 0.06% 95
2025
Q3 		$948K Sell
4,095
-273
-6% -$55.6K 0.06% 89
2025
Q2 		$811K Sell
4,368
-395
-8% -$73.4K 0.05% 97
2025
Q1 		$998K Sell
4,763
-859
-15% -$167K 0.08% 91
2024
Q4 		$999K Sell
5,622
-1,011
-15% -$186K 0.07% 99
2024
Q3 		$1.31M Buy
6,633
+188
+3% +$35.1K 0.09% 91
2024
Q2 		$1.11M Buy
6,445
+348
+6% +$57.6K 0.08% 100
2024
Q1 		$1.11M Buy
6,097
+352
+6% +$60.7K 0.08% 98
2023
Q4 		$890K Buy
5,745
+464
+9% +$67.6K 0.07% 103
2023
Q3 		$787K Sell
5,281
-400
-7% -$58.7K 0.07% 104
2023
Q2 		$765K Hold
5,681
– – 0.06% 107
2023
Q1 		$905K Hold
5,681
– – 0.07% 105
2022
Q4 		$918K Sell
5,681
-2,400
-30% -$368K 0.08% 105
2022
Q3 		$1.08M Buy
8,081
+2,137
+36% +$307K 0.1% 103
2022
Q2 		$910K Sell
5,944
-8,557
-59% -$1.31M 0.08% 108
2022
Q1 		$2.35M Buy
14,501
+2,064
+17% +$300K 0.17% 88
2021
Q4 		$1.68M Buy
12,437
+5,368
+76% +$634K 0.12% 100
2021
Q3 		$763K Buy
7,069
+852
+14% +$97.4K 0.06% 130
2021
Q2 		$700K Buy
6,217
+1,899
+44% +$214K 0.06% 126
2021
Q1 		$467K Buy
4,318
+243
+6% +$26K 0.04% 132
2020
Q4 		$437K Buy
4,075
+691
+20% +$66.4K 0.04% 128
2020
Q3 		$296K Sell
3,384
-1,178
-26% -$111K 0.03% 140
2020
Q2 		$448K Buy
4,562
+560
+14% +$49.3K 0.05% 122
2020
Q1 		$305K Sell
4,002
-414
-9% -$35.3K 0.04% 146
2019
Q4 		$391K Buy
4,416
+1,158
+36% +$96.1K 0.03% 138
2019
Q3 		$247K Buy
+3,258
New +$223K 0.03% 111
2019
Q1 		– Sell
-2,665
Closed -$246K – 121
2018
Q4 		$246K Buy
+2,665
New +$234K 0.03% 105
2018
Q2 		– Sell
-3,066
Closed -$290K – 107
2018
Q1 		$290K Sell
3,066
-800
-21% -$87.9K 0.05% 82
2017
Q4 		$374K Buy
3,866
+51
+1% +$4.81K 0.06% 70
2017
Q3 		$339K Sell
3,815
-250
-6% -$19K 0.06% 77
2017
Q2 		$295K Hold
4,065
– – 0.04% 101
2017
Q1 		$265K Sell
4,065
-250
-6% -$15.7K 0.04% 112
2016
Q4 		$270K Sell
4,315
-3,753
-47% -$229K 0.04% 116
2016
Q3 		$509K Buy
8,068
+13
+0.2% +$842 0.08% 80
2016
Q2 		$498K Buy
+8,055
New +$491K 0.08% 78
2015
Q3 		– Sell
-3,374
Closed -$227K – 77
2015
Q2 		$227K Buy
+3,374
New +$220K 0.04% 72
2015
Q1 		– Sell
-3,374
Closed -$221K – 76
2014
Q4 		$221K Buy
+3,374
New +$213K 0.04% 75

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BOK Financial Private Wealth's ABBV Position: Q1 2026 in Review

BOK Financial Private Wealth reduced its AbbVie (ABBV) stake by 6.6% in Q1 2026, selling an estimated $58.1K and leaving 3,714 shares worth $808K. The position accounts for 0.05% of the portfolio, ranked #93.

BOK Financial Private Wealth first reported a position in ABBV in Q4 2014 and has held it in 38 quarters since. The position peaked at $2.35M in Q1 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • BOK Financial Private Wealth held 3,714 shares of AbbVie worth $808K as of Q1 2026.
  • BOK Financial Private Wealth sold 262 AbbVie shares in Q1 2026, an estimated $58.1K.
  • AbbVie made up 0.05% of BOK Financial Private Wealth's portfolio in Q1 2026, its #93 holding.
  • BOK Financial Private Wealth first reported a position in AbbVie in Q4 2014 and has held it in 38 quarters since.
  • BOK Financial Private Wealth's AbbVie position peaked at $2.35M in Q1 2022.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on BOK Financial Private Wealth's 13F filing for Q1 2026, filed 12 May 2026.